
Opinion|Videos|August 1, 2024
The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer
Author(s)Kyrollis Attalla, MD
An expert on prostate cancer discusses how fusion-guided biopsy can help determine patient eligibility for focal therapy.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- How can fusion-guided biopsy help determine patient eligibility for focal therapy?
- What advantages do 3D MRI/US fusion biopsy systems offer over conventional biopsy methods in terms of focal therapy imaging and planning?
- How may better accuracy and precision in lesion identification help improve treatment outcomes in patients receiving focal therapy?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
MRI, myths, and precision: Stacy Loeb, MD, discusses modern prostate cancer screening
2
Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer
3
Dual targeting of PAM and AR pathways yields encouraging results in mCRPC
4
Suzanne Merrill, MD, on integrating ICIs into clinical practice for NMIBC
5






















